Sanofi Recalls Auvi-Q Epinephrine Auto-Injectors Due to Defective Delivery System
Sanofi-Aventis is recalling Auvi-Q epinephrine auto-injectors because a defective delivery system may result in inaccurate dosage delivery.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric, as the defective delivery system poses a significant risk of inadequate treatment for a life-threatening condition.
Plain-English summary
Sanofi-Aventis U.S. LLC is recalling approximately 383,900 prefilled syringes of Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg. The recall involves two specific NDC configurations: (a) 2 prefilled auto injectors + 1 trainer (NDC 0025-5833-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5833-00). The products were distributed nationwide.
The recall is being conducted because the auto-injectors have a defective delivery system that has the potential to deliver an inaccurate dosage of epinephrine. This defect could compromise the effectiveness of the medication during a medical emergency.
Consumers who have purchased these specific products should check their lot numbers and expiration dates against the list provided in the official recall notice. If the product matches the recalled lot numbers, consumers should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement.
The recalled product
- Product
- Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0025-5833-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5833-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Category
- Drug — Epinephrine Auto-Injector
- Affected units
- 383,900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) 2081278
- 2113841
- 2113842
- 2144138
- exp 10/2015
- 2440675
- exp 04/2016
- 2506456
- 2506460
- 2546946
- 2546947
- exp 05/2016
- 2620206
- 2620207
- 2659534
- exp 06/2016
- 2692111
- 2692112
- exp 07/2016
- 2716517
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sanofi-Aventis U.S. LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Sanofi-Aventis U.S. LLC
See all →- HighADMELOG Insulin Lispro Recalled for Malformed Seal Defect
FDA (Drugs) · 2023-05-24
- ModerateSanofi Recalls Elitek (Rasburicase) Vials Due to Stability Testing Failures
FDA (Drugs) · 2020-08-26
- SevereSanofi Recalls Zantac 150 mg Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
- SevereSanofi Recalls Zantac 150 mg Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
- SevereSanofi Recalls Zantac 75 mg Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
Same hazard · inaccurate dosage
See all →- HighICU Medical Recalls IV Administration Sets with Incorrect Drop Cannula
FDA (Devices) · 2020-05-13
- HighINOmax DSIR Plus Delivery System Recalled for Inaccurate Valve Calibration
FDA (Devices) · 2017-02-01
- CriticalSanofi Recalls Auvi-Q Epinephrine Auto-Injectors Due to Defective Delivery System
FDA (Drugs) · 2016-06-01